Bayer obtains the opportunity for a Supreme Court hearing to challenge the Roundup herbicide cancer lawsuit
The U.S. Supreme Court has agreed to hear Bayer AG's appeal. The company aims to challenge thousands of lawsuits alleging that its Roundup herbicide causes cancer.
Bayer executives hope that the Supreme Court's ruling will help overturn thousands of cases that include failure-to-warn claims, which the company believes are preempted by federal law. Currently, Bayer still faces claims from approximately 67,000 plaintiffs who allege that long-term exposure to the main ingredient in Roundup, glyphosate, has caused them to develop cancer, while Bayer insists that the herbicide is safe.
Bayer ADR rose 5%, hitting a daily high
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments